Lv4
720 积分 2021-09-17 加入
Efficacy, Safety, and Influence on Tumor Microenvironment of Neoadjuvant Pembrolizumab plus Ramucirumab for PD-L1 Positive NSCLC: A Phase 2 Trial (EAST ENERGY)
3小时前
已完结
Surgical and safety outcomes in patients with non-small cell lung cancer receiving neoadjuvant chemoimmunotherapy versus chemotherapy alone: A systematic review and meta-analysis
17小时前
已完结
Perioperative immunotherapy for nonsmall cell lung cancer
17小时前
求助中
Neoadjuvant immunotherapy in early-stage NSCLC: navigating biomarker dilemmas and special population challenges
17小时前
已完结
Neoadjuvant versus perioperative chemo-immunotherapy according to pathological response in resectable NSCLC: a reconstructed individual patient data meta-analysis
17小时前
已完结
Immune Checkpoint Inhibitor-induced Myositis
7天前
已完结
Adjuvant therapy in stage IB non-small cell lung cancer: a network meta-analysis of tegafur-uracil and immune checkpoint inhibitors
11天前
已关闭
Immune-Mediated Myopathies and Neuropathies
14天前
已完结
The Basics of Cancer Immunotherapy
14天前
已完结
Immune checkpoint inhibitor-related myasthenia gravis, myocarditis and myositis: further insights
14天前
已完结
皖公网安备34019202002308
